Abstract
Cardiovascular disease is a leading cause of increased morbidity and mortality in cats, with hypertrophic cardiomyopathy (HCM) significantly overrepresented. While feline HCM is hereditary, the genetic etiology of disease remains poorly understood. Establishing a cohort of well-phenotyped and -genotyped healthy control cats is essential to fuel future genetic/pharmacogenetic discoveries. We sought to construct a robust genetic sequencing and gene expression library from cardiovascularly healthy cats using whole genome sequencing (WGS) and RNA sequencing (RNA-Seq). Fifty-four client-owned cats (10 years) were screened, of which 18 cats (cohort 1) were prospectively enrolled after being deemed cardiovascularly healthy by clinicopathology, biochemistry, and echocardiography. DNA isolated from blood samples was submitted for paired-end WGS at ~ 30X coverage. Standard pipelines were employed for variant calling across sequenced cats. A second cohort of 15 purpose-bred cats were euthanized for non-cardiac reasons. Flash-frozen left ventricular (LV), interventricular septum (IVS), and left atrium (LA) tissues from 11, 14, and 13 cats, respectively, were submitted for stranded mature RNA-Seq at 50 million reads/sample. Gene variants and expression profiling were catalogued for both meticulously selected cohorts. Transcriptomic and WGS data libraries were generated to serve as an open-access resource in future investigations of feline cardiovascular precision medicine.
| Original language | English (US) |
|---|---|
| Article number | 22051 |
| Journal | Scientific reports |
| Volume | 15 |
| Issue number | 1 |
| DOIs | |
| State | Published - Dec 2025 |
| Externally published | Yes |
Keywords
- Hypertrophic cardiomyopathy
- Individualized medicine
- Normal
- Precision medicine
- RNA sequencing
- Whole genome sequencing
ASJC Scopus subject areas
- General